Afficher la couverture 'International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up | Altassan, Ruqaiah' en grand format
/5

0 avis

International clinical guidelines for the management of phosphomannomutase 2‐congenital disorders of glycosylation: Diagnosis, treatment and follow up

Archive ouverte

Altassan, Ruqaiah | Péanne, Romain | Jaeken, Jaak | Barone, Rita | Bidet, Muad | Borgel, Delphine | Brasil, Sandra | Cassiman, David | Cechova, Anna | Coman, David | Corral, Javier | Correia, Joana | de la Morena-Barrio, María Eugenia | de Lonlay, Pascale | dos Reis, Vanessa | Ferreira, Carlos | Fiumara, Agata | Francisco, Rita | Freeze, Hudson | Funke, Simone | Gardeitchik, Thatjana | Gert, Matthijs | Girad, Muriel | Giros, Marisa | Grünewald, Stephanie | Hernández-Caselles, Trinidad | Honzik, Tomas | Hutter, Marlen | Krasnewich, Donna | Lam, Christina | Lee, Joy | Lefeber, Dirk | Marques-Da-Silva, Dorinda | Martinez-Monseny, Antonio | Moravej, Hossein | Õunap, Katrin | Pascoal, Carlota | Pascreau, Tiffany | Patterson, Marc | Quelhas, Dulce | Raymond, Kimiyo | Sarkhail, Peymaneh | Schiff, Manuel | Seroczyńska, Małgorzata | Serrano, Mercedes | Seta, Nathalie | Sykut-Cegielska, Jolanta | Thiel, Christian | Tort, Federic | Vals, Mari‐anne | Videira, Paula | Witters, Peter | Zeevaert, Renate | Morava, Eva

Edité par CCSD ; Springer Verlag -

International audience. Abstract Phosphomannomutase 2 (PMM2‐CDG) is the most common congenital disorder of N‐glycosylation and is caused by a deficient PMM2 activity. The clinical presentation and the onset of PMM2‐CDG vary among affected individuals ranging from a severe antenatal presentation with multisystem involvement to mild adulthood presentation limited to minor neurological involvement. Management of affected patients requires a multidisciplinary approach. In this article, a systematic review of the literature on PMM2‐CDG was conducted by a group of international experts in different aspects of CDG. Our managment guidelines were initiated based on the available evidence‐based data and experts' opinions. This guideline mainly addresses the clinical evaluation of each system/organ involved in PMM2‐CDG, and the recommended management approach. It is the first systematic review of current practices in PMM2‐CDG and the first guidelines aiming at establishing a practical approach to the recognition, diagnosis and management of PMM2‐CDG patients.

Consulter en ligne

Suggestions

Du même auteur

Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?

Archive ouverte | Witters, Peter | CCSD

International audience

Consensus guideline for the diagnosis and management of mannose phosphate isomerase‐congenital disorder of glycosylation

Archive ouverte | Čechová, Anna | CCSD

International audience. Abstract Mannose phosphate isomerase‐congenital disorder of glycosylation (MPI‐CDG) deficiency is a rare subtype of congenital disorders of protein N ‐glycosylation. It is characterised by de...

Congenital disorders of glycosylation (CDG): Quo vadis ?

Archive ouverte | Péanne, Romain | CCSD

The survey summarizes in its first part the current status of knowledge on the Congenital Disorders of Glycosylation (CDG) with regard to their phenotypic spectrum, diagnostic and therapeutic strategies, and pathophysiology. It do...

Chargement des enrichissements...